Nicole Vitullo insider trades: Marinus Pharmaceuticals (MRNS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nicole reports to the SEC
and 26 more companies
Open-market buys and sales
169 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 15, 2021 | MRNS | ↓ Sell | 4,250 | $15.87 | $67K | By DP VI Associates, L.P. | Mar 16, 2021 (1d) |
| Aug 6, 2019 | OBLN | ↑ Buy | 250,000 | $4.00 | $1.0M | Direct | Aug 8, 2019 (2d) |
| Mar 19, 2019 | ESPR | ↓ Sell | 15,329 | $44.73 | $686K | By DP VII Associates, L.P. | Mar 21, 2019 (2d) |
| Aug 23, 2018 | OBLN | ↑ Buy | 1,648,359 | $1.82 | $3.0M | Direct | Aug 27, 2018 (4d) |
| Aug 23, 2018 | BNGO | ↑ Buy | 15,000 | $6.13 | $92K | Direct | Aug 27, 2018 (4d) |
| Jan 25, 2018 | ESPR | ↓ Sell | 11,674 | $71.79 | $838K | By DP VII Associates, L.P. | Jan 26, 2018 (1d) |
| Dec 6, 2017 | ESPR | ↓ Sell | 9,326 | $53.85 | $502K | By DP VII Associates, L.P. | Dec 8, 2017 (2d) |
| Aug 3, 2016 | CLCD | ↓ Sell | 153,028 | $8.45 | $1.3M | Direct | Aug 3, 2016 (0d) |
| Aug 3, 2016 | CLCD | ↓ Sell | 245 | $8.45 | $2K | Direct | Aug 3, 2016 (0d) |
| May 26, 2016 | EVOK | ↓ Sell | 344,120 | $4.70 | $1.6M | Direct | May 27, 2016 (1d) |
| May 26, 2016 | EVOK | ↓ Sell | 5,880 | $4.70 | $28K | Direct | May 27, 2016 (1d) |
| Apr 28, 2016 | CLCD | ↓ Sell | 149,765 | $6.96 | $1.0M | Direct | May 2, 2016 (4d) |
| Apr 28, 2016 | CLCD | ↓ Sell | 235 | $6.96 | $2K | Direct | May 2, 2016 (4d) |
| Apr 27, 2016 | EVOK | ↓ Sell | 5,095 | $5.07 | $26K | Direct | Apr 27, 2016 (0d) |
| Apr 27, 2016 | EVOK | ↓ Sell | 82 | $5.07 | $415 | Direct | Apr 27, 2016 (0d) |
| Apr 20, 2016 | EVOK | ↓ Sell | 41,478 | $5.35 | $222K | Direct | Apr 21, 2016 (1d) |
| Apr 20, 2016 | EVOK | ↓ Sell | 708 | $5.35 | $4K | Direct | Apr 21, 2016 (1d) |
| Apr 11, 2016 | EVOK | ↓ Sell | 4,348 | $5.22 | $23K | Direct | Apr 13, 2016 (2d) |
| Apr 11, 2016 | EVOK | ↓ Sell | 75 | $5.22 | $392 | Direct | Apr 13, 2016 (2d) |
| Apr 8, 2016 | EVOK | ↓ Sell | 51,004 | $5.28 | $269K | Direct | Apr 8, 2016 (0d) |
| Apr 8, 2016 | EVOK | ↓ Sell | 874 | $5.28 | $5K | Direct | Apr 8, 2016 (0d) |
| Nov 11, 2015 | ACHN | ↓ Sell | 545,930 | $10.17 | $5.6M | By Domain Partners VIII, L.P. | Nov 12, 2015 (1d) |
| Nov 11, 2015 | ACHN | ↓ Sell | 4,070 | $10.17 | $41K | By DP VIII Associates, L.P. | Nov 12, 2015 (1d) |
| Sep 25, 2015 | ACHN | ↓ Sell | 9,241 | $8.22 | $76K | By Domain Partners VIII, L.P. | Sep 29, 2015 (4d) |
| Sep 25, 2015 | ACHN | ↓ Sell | 69 | $8.22 | $567 | By DP VIII Associates, L.P. | Sep 29, 2015 (4d) |
| Aug 18, 2015 | EVOK | ↓ Sell | 11,836 | $7.02 | $83K | Direct | Aug 20, 2015 (2d) |
| Aug 18, 2015 | EVOK | ↓ Sell | 202 | $7.02 | $1K | Direct | Aug 20, 2015 (2d) |
| Aug 14, 2015 | ACHN | ↓ Sell | 37,843 | $7.51 | $284K | By DP VIII Associates, L.P. | Aug 18, 2015 (4d) |
| May 4, 2015 | TBRA | ↑ Buy | 277,777 | $10.62 | $2.9M | Direct | May 6, 2015 (2d) |
| Apr 16, 2015 | EVOK | ↓ Sell | 50,163 | $7.29 | $366K | Direct | Apr 16, 2015 (0d) |
| Apr 16, 2015 | EVOK | ↓ Sell | 857 | $7.29 | $6K | Direct | Apr 16, 2015 (0d) |
| Nov 25, 2014 | NEOT | ↑ Buy | 70,000 | $14.00 | $980K | Direct | Nov 26, 2014 (1d) |
| Oct 21, 2014 | ESPR | ↑ Buy | 500,000 | $20.00 | $10.0M | Direct | Oct 21, 2014 (0d) |
| Oct 21, 2014 | ATRA | ↑ Buy | 248,159 | $11.00 | $2.7M | Direct | Oct 21, 2014 (0d) |
| Oct 21, 2014 | ATRA | ↑ Buy | 1,841 | $11.00 | $20K | Direct | Oct 21, 2014 (0d) |
| Aug 5, 2014 | MRNS | ↑ Buy | 419,744 | $8.00 | $3.4M | Direct | Aug 7, 2014 (2d) |
| Jan 16, 2014 | ALIM | ↓ Sell | 296,760 | $6.39 | $1.9M | Direct | Jan 17, 2014 (1d) |
| Jan 16, 2014 | ALIM | ↓ Sell | 3,240 | $6.39 | $21K | Direct | Jan 17, 2014 (1d) |
| Aug 27, 2013 | RGDO | ↑ Buy | 750,000 | $4.00 | $3.0M | By Domain Partners VI, L.P. | Aug 28, 2013 (1d) |
| Jul 15, 2013 | OCRX | ↑ Buy | 988,285 | $6.03 | $6.0M | By Domain Partners VIII, L.P. | Jul 16, 2013 (1d) |
| Jul 15, 2013 | OCRX | ↑ Buy | 331,873 | $6.03 | $2.0M | By Domain Partners VI, L.P. | Jul 16, 2013 (1d) |
| Jul 15, 2013 | OCRX | ↑ Buy | 7,333 | $6.03 | $44K | By DP VIII Associates, L.P. | Jul 16, 2013 (1d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 280,923 | $14.00 | $3.9M | By Domain Partners VII, L.P. | Jul 2, 2013 (1d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 4,791 | $14.00 | $67K | By DP VII Associates, L.P. | Jul 2, 2013 (1d) |
| Jun 20, 2013 | ALIM | ↓ Sell | 10,516 | $5.01 | $53K | Direct | Jun 24, 2013 (4d) |
| Jun 20, 2013 | ALIM | ↓ Sell | 114 | $5.01 | $571 | Direct | Jun 24, 2013 (4d) |
| Jun 19, 2013 | ALIM | ↓ Sell | 55,278 | $5.39 | $298K | Direct | Jun 20, 2013 (1d) |
| Jun 19, 2013 | ALIM | ↓ Sell | 603 | $5.39 | $3K | Direct | Jun 20, 2013 (1d) |
| Jun 17, 2013 | ALIM | ↓ Sell | 126,709 | $5.29 | $670K | Direct | Jun 18, 2013 (1d) |
| Jun 17, 2013 | ALIM | ↓ Sell | 1,384 | $5.29 | $7K | Direct | Jun 18, 2013 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Nicole Vitullo's insider trades
Nicole Vitullo is a director at Marinus Pharmaceuticals (MRNS). Since Sep 18, 2006, Nicole has reported 50 open-market purchases worth $117.0M and 119 sales worth $41.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (41 filings), other transactions (40 filings), grants and awards (38 filings), shares returned to the company (13 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.